• clinical
  • Bataille R, Sany J. Solitary myeloma: clinical and prognostic features of a review of 114 cases. (medscape.com)
  • During forecast period 2017 - 2025, stem cell transplantation therapies segment is expected to be the fastest growing segments as approved personalized cellular therapy for advanced leukemia named chimeric antigen receptor (CAR) T-cell therapy is under clinical trials for multiple myeloma and its approval is expected to boost the growth of multiple myeloma treatment market in the near future. (michigannewsupdates.com)
  • Cancer
  • North America accounted for the largest share in global multiple myeloma treatment market due to key driving factors such as rising prevalence of multiple myeloma, high awareness associated with early cancer diagnosis and treatment, supportive reimbursement policies, and developed healthcare infrastructure. (michigannewsupdates.com)